Tecan is proud to offer end-to-end cellomics workflow solutions, including cell seeding and culture with quality control and monitoring, through drug dosing to live-cell imaging and analysis. This comprehensive offering enables laboratories to improve the reliability, reproducibility and throughput of their workflows, addressing key challenges in the growing field of 3D cell biology.
Aqemia wins $32.5m for generative AI-powered drug discovery platform – Pharmaceutical Technology
Share this article The company spun out of École normale supérieure in 2019 with already assimilated knowledge of quantum physics algorithms. Image credit: Shutterstock/TSViPhoto. Paris-based
January 30, 2024